General Information of Drug (ID: DM1K3ER)

Drug Name
DS102
Indication
Disease Entry ICD 11 Status REF
Chronic obstructive pulmonary disease CA22 Phase 2 [1]
Cross-matching ID
TTD ID
DGL7Z2

References

1 ClinicalTrials.gov (NCT03414541) A Randomised, Double-Blind, Placebo-Controlled, Exploratory Phase IIa Study To Assess The Safety And Efficacy Of Orally Administered DS102 In Chronic Obstructive Pulmonary Disease Patients. U.S.National Institutes of Health.